High-risk group1 | ||||
---|---|---|---|---|
Characteristic | (A) Severely immunocompromised | (B) Critically ill | (C) Mildly/moderately immunocompromised | (D) Major surgery or Pneumonia |
Mucormycosis Cohort | ||||
N (weighted) | 2,623 | 1,067 | 1,364 | 292 |
Length of stay (days) | ||||
Mean (SD) | 25.6 (34.0) | 35.6 (37.9) | 14 (15.7) | 22.5 (30.59) |
Median (IQR) | 15 (6–32) | 25 (10–45) | 8 (4–20) | 16 (8–24) |
Mortality (%) | 23.4% | 35.3% | 9.4% | 21.3% |
Total Charges | ||||
Mean (SD) | $255,708 ($292,863) | $361,607 ($366,468) | $124,187 ($140,931) | $174,256 ($183,497) |
Median (IQR) | $140,867 ($54,693 - $345,646) | $216,589 ($93,922 - $525,537) | $68,281 ($27,062 - $161,126) | $108,226 ($61,543 - $225,011) |
Total Costs | ||||
Mean (SD) | $98,365 ($117,047) | $134,082 ($145,047) | $46,923 ($54,558) | $73,748 ($75,906) |
Median (IQR) | $56,267 ($22,533 - $122,632) | $85,106 ($33,613 - $173,195) | $24,546 ($10,542 - $62,435) | $45,832 ($20,356 - $92,340) |
Non-mucormycosis Cohort | ||||
N (weighted) | 7,839 | 3,488 | 3,804 | 867 |
Length of stay (days) | ||||
Mean (SD) | 8.2 (10.67) | 10.9 (17.9) | 5.3 (6.12) | 5.6 (7.8) |
Median (IQR) | 5 (3–9) | 6 (3–13) | 4 (2–6) | 3 (2–6) |
Mortality (%) | 3.7% | 9.6% | 1.5% | 1.7% |
Total Charges | ||||
Mean (SD) | $77,591 ($125,386) | $96,878 ($136,883) | $38,373 ($48,383) | $62,714 ($77,071) |
Median (IQR) | $36,391 ($17,814 - $83,945) | $45,347 ($20,938 - $110,051) | $24,693 ($13,589 - $44,194) | $37,087 ($21,023 - $70,037) |
Total Costs | ||||
Mean (SD) | $28,301 ($45,397) | $32,694 ($48,476) | $14,393 ($18,339) | $25,568 ($32,338) |
Median (IQR) | $13,229 ($6,618 - $31,261) | $15,488 ($7,820 - $36,035) | $9,094 ($5,168 - $16,155) | $14,343 ($7,534 - $31,615) |